Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CU-20401 for Submental Fat Accumulation
NCT05195541Phase 2Completed
- Sponsor
- Cutia Therapeutics
- Start
- Feb 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CU-20401 in submental lipohypertrophy, sponsored by Cutia Therapeutics. Started Feb 2022; status: completed.
02
Drugs
CU-20401
03
Conditions
submental lipohypertrophy
Beyond the preview
Go deeper on NCT05195541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195541.